tiprankstipranks
S2Medical AB Class B (DE:S21)
FRANKFURT:S21
Germany Market
S21
S2Medical AB Class B
RESEARCH TOOLSreports

S2Medical AB Class B (S21) Ratios

0 Followers

S2Medical AB Class B Ratios

DE:S21's free cash flow for Q4 2025 was kr0.91. For the 2025 fiscal year, DE:S21's free cash flow was decreased by kr and operating cash flow was kr-0.25. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 0.56 0.56 0.92 0.44 0.65
Quick Ratio
 0.51 0.51 0.65 0.18 0.30
Cash Ratio
 0.13 0.13 0.16 0.08 0.20
Solvency Ratio
 -1.29 -1.25 1.08 -1.06 -1.54
Operating Cash Flow Ratio
 0.19 0.10 0.50 -0.84 -1.54
Short-Term Operating Cash Flow Coverage
 0.00 0.00 0.00 0.00 0.00
Net Current Asset Value
kr -3.07Mkr -3.07Mkr -496.76Kkr -11.12Mkr -6.29M
Leverage Ratios
Debt-to-Assets Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Equity Ratio
 0.00 0.00 0.00 0.00 0.00
Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.71 1.71 1.53 12.91 3.58
Debt Service Coverage Ratio
 -36.45 -234.17 341.15 -1.82 -15.91
Interest Coverage Ratio
 -45.85 -446.83 289.55 -2.05 -15.66
Debt to Market Cap
 0.00 0.00 0.00 0.00 0.00
Interest Debt Per Share
 <0.01 <0.01 <0.01 0.05 0.03
Net Debt to EBITDA
 0.46 0.65 -0.15 0.11 0.14
Profitability Margins
Gross Profit Margin
90.37%-14.39%94.86%72.25%110.60%
EBIT Margin
-15.35%-18.67%38.85%-218.95%-592.88%
EBITDA Margin
-10.24%-9.78%45.77%-194.08%-564.56%
Operating Profit Margin
-15.35%-18.67%38.85%-218.95%-592.88%
Pretax Profit Margin
-54.32%-70.27%38.72%-325.73%-630.73%
Net Profit Margin
-52.37%-70.27%38.72%-325.73%-630.73%
Continuous Operations Profit Margin
-56.28%-70.27%32.28%-325.73%-630.73%
Net Income Per EBT
96.40%100.00%100.00%100.00%100.00%
EBT Per EBIT
353.95%376.43%99.65%148.76%106.38%
Return on Assets (ROA)
-59.24%-59.71%31.90%-106.07%-116.46%
Return on Equity (ROE)
-69.64%-102.18%48.90%-1369.60%-416.69%
Return on Capital Employed (ROCE)
-29.72%-27.15%49.06%-920.65%-391.68%
Return on Invested Capital (ROIC)
-29.72%-27.16%48.57%-920.65%-391.68%
Return on Tangible Assets
-240.48%-242.37%95.04%-242.27%-224.54%
Earnings Yield
-250.39%-110.09%98.17%-311.54%-81.60%
Efficiency Ratios
Receivables Turnover
 12.29 9.22 6.41 4.83 2.82
Payables Turnover
 2.02 18.11 2.15 0.56 -0.28
Inventory Turnover
 4.68 41.75 0.46 0.37 -0.08
Fixed Asset Turnover
 94.40 71.09 37.08 9.32 3.94
Asset Turnover
 1.13 0.85 0.82 0.33 0.18
Working Capital Turnover Ratio
 -6.23 -8.06 -2.57 -0.80 -1.86
Cash Conversion Cycle
 -72.63 28.19 689.14 394.51 -3.28K
Days of Sales Outstanding
 29.70 39.60 56.98 75.54 129.34
Days of Inventory Outstanding
 78.01 8.74 801.79 974.05 -4.71K
Days of Payables Outstanding
 180.34 20.15 169.63 655.08 -1.31K
Operating Cycle
 107.71 48.34 858.77 1.05K -4.58K
Cash Flow Ratios
Operating Cash Flow Per Share
 <0.01 <0.01 <0.01 -0.10 -0.41
Free Cash Flow Per Share
 <0.01 >-0.01 <0.01 -0.11 -0.44
CapEx Per Share
 <0.01 <0.01 <0.01 <0.01 0.03
Free Cash Flow to Operating Cash Flow
 0.24 -2.00 0.80 1.07 1.07
Dividend Paid and CapEx Coverage Ratio
 1.31 1.00 4.92 -14.30 -14.81
Capital Expenditure Coverage Ratio
 1.31 1.00 4.92 -14.30 -14.81
Operating Cash Flow Coverage Ratio
 0.00 0.00 0.00 0.00 0.00
Operating Cash Flow to Sales Ratio
 0.07 0.05 0.21 -2.37 -6.02
Free Cash Flow Yield
5.66%-14.70%42.32%-242.49%-83.19%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.40 -0.91 1.02 -0.32 -1.23
Price-to-Sales (P/S) Ratio
 0.29 0.64 0.39 1.05 7.73
Price-to-Book (P/B) Ratio
 0.40 0.93 0.50 4.40 5.11
Price-to-Free Cash Flow (P/FCF) Ratio
 17.67 -6.80 2.36 -0.41 -1.20
Price-to-Operating Cash Flow Ratio
 3.03 13.58 1.88 -0.44 -1.28
Price-to-Earnings Growth (PEG) Ratio
 <0.01 <0.01 >-0.01 <0.01 -0.04
Price-to-Fair Value
 0.40 0.93 0.50 4.40 5.11
Enterprise Value Multiple
 -2.38 -5.88 0.71 -0.43 -1.23
Enterprise Value
 4.66M 8.26M 4.87M 5.77M 32.37M
EV to EBITDA
 -2.38 -5.88 0.71 -0.43 -1.23
EV to Sales
 0.24 0.58 0.33 0.83 6.93
EV to Free Cash Flow
 14.79 -6.13 1.96 -0.33 -1.08
EV to Operating Cash Flow
 3.53 12.24 1.56 -0.35 -1.15
Tangible Book Value Per Share
 >-0.01 >-0.01 >-0.01 -0.07 -0.07
Shareholders’ Equity Per Share
 0.01 0.01 0.02 0.01 0.10
Tax and Other Ratios
Effective Tax Rate
 -0.04 0.00 0.00 0.00 -0.06
Revenue Per Share
 0.02 0.02 0.03 0.04 0.07
Net Income Per Share
 -0.01 -0.01 0.01 -0.14 -0.43
Tax Burden
 0.96 1.00 1.00 1.00 1.00
Interest Burden
 3.54 3.76 1.00 1.49 1.06
Research & Development to Revenue
 0.03 0.00 0.00 0.09 0.13
SG&A to Revenue
 0.81 0.00 1.01 0.00 0.00
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 -0.12 -0.07 0.54 1.08 1.02
Currency in SEK